Target intelligence / Profile preview

Snf2-related CREBBP activator protein (SRCAP)

Target
SRCAP
Molecular classification
Chromatin remodeler, ATP-dependent helicase, Swi2/Snf2-related ATPase, Histone modification complex component
01

Overview

Snf2-related CREBBP activator protein (SRCAP) is the **scaffold and ATPase subunit of the human SRCAP chromatin remodeling complex**, structurally and functionally homologous to yeast SWR1. SRCAP catalyzes **ATP-dependent histone exchange**, specifically replacing canonical histone H2A-H2B dimers with the H2A.Z-H2B variant complex, thus regulating chromatin structure and gene expression[1][3][4]. The complex does not support net nucleosome sliding but instead facilitates deposition of H2A.Z, a modification associated with transcriptional regulation and promoter activity[1][3]. SRCAP is implicated in **epigenetic control, cellular differentiation, and development**, with mutations causing Floating-Harbor syndrome (FLHS), a neurodevelopmental disorder, and involvement reported in several cancers[4]. There are currently no drugs known to directly target SRCAP, but it is being studied as a potential epigenetic enzyme and therapeutic target.

Other names
Helicase SRCAPKIAA0309SWR1DOMO1Domino homolog 2Snf2-related CBP activatorSwi2/Snf2-related ATPase homologdomino homolog 1DEHMBAEAF1FLHShelicase SRCAPSnf2-related CBP activator proteindomino homolog 2
02

Mechanism of action

ATP-dependent DNA translocation and histone exchange; transcription regulation via histone variant deposition (H2A.Z)

03

Biological functions

Histone exchange (specifically H2A.Z-H2B for H2A-H2B)Chromatin remodelingRegulation of transcriptionEpigenetic regulation
04

Disease associations

CancerFloating-Harbor syndrome (FLHS)Developmental disorders (e.g., neurodevelopmental syndromes)
05

Safety considerations

No directly reported drug safety concerns; disease phenotypes from loss-of-function include developmental syndrome (Floating-Harbor syndrome) and possible cancer predisposition
06

Biomarkers

Mutations and levels of SRCAP may serve as biomarkers in Floating-Harbor syndrome and some cancers

Beyond the preview

Go deeper on Snf2-related CREBBP activator protein (SRCAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snf2-related CREBBP activator protein (SRCAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call